Metabolite

Metabolite refers to any compound the body produces while chemically transforming a drug — the product left after the liver and other tissues have broken the original molecule apart or modified its structure. Metabolism does not simply neutralise substances; it creates new chemical entities, each with its own biological activity.

Some metabolites are pharmacologically inactive and are cleared without further effect. Others remain active — capable of binding receptors, extending effects, or changing the character of what the original substance started. A smaller number are toxic, contributing to harm at doses where the parent compound alone would not.

How it works · its role

The liver is the primary site of drug metabolism, relying on a large enzyme family called the cytochrome P450 (CYP) system to chemically modify drug molecules. In Phase I reactions these enzymes carry out oxidation, reduction, or hydrolysis, altering the molecule's structure. In Phase II, the resulting compound is typically joined to a larger group — a sugar, amino acid, or similar molecule — to make it water-soluble and easier to excrete in urine or bile.

What emerges from this process may be structurally close to the parent drug or substantially different. The balance between parent compound and metabolites in the bloodstream depends on how active the relevant enzymes are — and that activity varies between individuals because of genetic differences. Two people who take the same dose can metabolise it at very different rates, reaching different peak concentrations and durations.

Relevance to substances & effects

Whether a metabolite is active or inactive shapes the entire arc of a substance's effects. Psilocybin is a prominent example: the compound itself is pharmacologically inert; the body converts it to psilocin, which binds 5-HT₂A receptors and drives the psychedelic experience. In this sense psilocybin is a prodrug — it exists primarily as a delivery mechanism for its active metabolite.

Codeine reaches opioid receptors largely as morphine, produced by the enzyme CYP2D6. People carrying gene variants that make them ultra-rapid metabolisers can reach high opioid concentrations from a dose most handle without incident — a well-documented source of adverse outcomes with standard prescribing.

Long-acting benzodiazepines such as diazepam generate chains of active metabolites that persist for days, extending both effects and withdrawal risk well beyond the drug's nominal half-life. This is why duration entries on these pages may look shorter than the full experience users report.

Active metabolites also appear on drug screening tests. The THC metabolite most commonly detected in urine (THC-COOH) is pharmacologically inactive but can remain measurable for weeks in regular cannabis users — a practical consideration that affects many people reading these pages.